Recordati Industria Chimica e Farmaceutica S.p.A
Research Recordati Industria Chimica e Farmaceutica S.p.A (REC.MI) on Bullrun: market cap EUR 10.69B, P/E 21.9, dividend yield 2.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerREC.MI
- ExchangeMTAA
- CountryItaly
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyEUR
- Market capEUR 10.69B
- P/E21.9
- Dividend yield2.5%
- Financial periodQ2 2026
- RevenueEUR 697.36M
- Net incomeEUR 116.61M
- Free cash flowEUR 155.89M
- Gross margin71.4%
Valuation Snapshot
latest market cap is EUR 10.69B; P/E is 21.9; dividend yield is 2.5%.
Peer valuation comparison
Latest P/E is 21.93x versus a Healthcare sector median of 24.67x (11.1% below).
Latest dividend yield is 2.53% versus a Healthcare sector median of 1.84% (37.5% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-05 | EUR 10.69B | 21.9 | 2.7% | 1.42 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.42 EUR, yield 2.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.3 EUR |
| FY2024 | 1.23 EUR |
| FY2023 | 1.17 EUR |
| FY2022 | 1.12 EUR |
About Recordati Industria Chimica e Farmaceutica S.p.A
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops Maapliv for maple syrup urine disease; Isturia for endogenous Cushing's syndrome; Cystadrops treatment of the ocular manifestations of cystinosis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Recordati Industria Chimica e Farmaceutica S.p.A's market cap?
Recordati Industria Chimica e Farmaceutica S.p.A's market capitalization is EUR 10.69B.
What is Recordati Industria Chimica e Farmaceutica S.p.A's P/E ratio?
Recordati Industria Chimica e Farmaceutica S.p.A's price-to-earnings (P/E) ratio is 21.9.
Does Recordati Industria Chimica e Farmaceutica S.p.A pay a dividend?
Recordati Industria Chimica e Farmaceutica S.p.A has a dividend yield of 2.5%.
What does Recordati Industria Chimica e Farmaceutica S.p.A do?
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments.